Gyongyi Szabo
Chair, Professor and Vice Chair for Research, Department of Medicine · University of Pennsylvania Health System
Credentials: · · · ·
History
PresentProfessor and Vice Chair for Research Department · University of Pennsylvania Health System
- 1984–1987
Internal Medicine
Research
Review · Nature Reviews Disease Primers · 2018 · 1,044 citations
Hepatology · 2020 · 724 citations
COVID-19 tissue atlases reveal SARS-CoV-2 pathology and cellular targets
Nature · 2021 · 648 citations
- AD
45 papers
27 papers
26 papers · 12 as a resident
26 papers
- TC
26 papers · 8 as a resident
23 papers
- AS
20 papers · 7 as a resident
18 papers · 4 as a resident
Grants
- 2026–2031
Myeloid-Derived Suppressor Cells in Alcohol-Associated Steatohepatitis
National Institute on Alcohol Abuse and Alcoholism · R01
Contact PI · $682.7K · Beth Israel Deaconess Medical Center
- 2025–2030
Innate Immune Dysregulation in Alcohol-Associated Liver Disease
National Institute on Alcohol Abuse and Alcoholism · R01
Contact PI · $1.4M · Beth Israel Deaconess Medical Center
- 1998–2029
Alcohol and Monocyte Signaling
National Institute on Alcohol Abuse and Alcoholism · R01
Contact PI · $9.8M · Beth Israel Deaconess Medical Center
- 2009–2026
Innate Immune Signaling in Alcoholic Liver Disease
National Institute on Alcohol Abuse and Alcoholism · R56
Contact PI · $578.6K · Beth Israel Deaconess Medical Center
Clinical trials
- 2017–2018
A Pilot, Dose Escalating Study on VLX103 in Moderate Alcoholic Steatohepatitis
Principal investigator · Withdrawn · Phase 1
Gyongyi Szabo
- 2000–2009
Long Term Interferon for Patients Who Did Not Clear Hepatitis C Virus With Standard Treatment
Principal investigator · Completed · Phase 3
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)